An Israeli bone-graft product made of enhanced coral has received CE approval to start sales in Europe for dental and orthopedic procedures. This unique product is made from corals grown in a closed system using patented technology to provide bioactivity and eliminate biological contamination. Many practitioners and medical device companies have

already contacted CoreBone to learn more about its advantages over currently available products for bone grafting, says CEO Ohad Schwartz. “Bone grafts ideally should have four features,” he explains. “They must be bioactive, not just a passive scaffold, in order to attract new bone cells; READ MORE